AB

Aristo Bio-Tech & Lifescience Ltd

Q2 FY27Fertilizers & Agrochemicals

Aristo Bio-Tech & Lifescience Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Aristo Bio-Tech & Lifescience Ltd Q2 FY27 key numbers

Revenue
Other income was Rs. 15.94 lakh versus Rs. 8.61 lakh for the same period last year.

As stated in Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.

Based on Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

Price₹118
Market cap₹80 Cr
P/E11.2

The short version

Revenue from operations for the half year ended 30th September 2026 was Rs. 19,824.17 lakh, compared to Rs. 25,645.31 lakh for the half year ended 30th September 2025, indicating a year-on-year decrea. EBITDA for the quarter ended September 30, 2026: Rs. 1,168.88 lakh (calculated as Profit Before Tax + Tax + Finance Cost + Depreciation = 659.84 + 169.65 + 175.57 + 157.33), showing a YoY change com.

From Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.

How did Aristo Bio-Tech & Lifescience's revenue grow in the September 2026 quarter?

  • Revenue from operations for the half year ended 30th September 2026 was Rs. 19,824.17 lakh, compared to Rs. 25,645.31 lakh for the half year ended 30th September 2025, indicating a year-on-year decrease.
  • Other income was Rs. 15.94 lakh versus Rs. 8.61 lakh for the same period last year.
  • Total revenue (operations plus other income) for the half year ended 30th September 2026 was Rs. 19,840.11 lakh, down from Rs. 25,653.93 lakh a year ago.

What happened to Aristo Bio-Tech & Lifescience's margins in Q2 FY27?

EBITDA for the quarter ended September 30, 2026: Rs. 1,168.88 lakh (calculated as Profit Before Tax + Tax…

Locked: what Aristo Bio-Tech & Lifescience Ltd said on margins

Also locked on this page: capex, fundraising, order book

Free account, 30 seconds. No card needed.

What capex is Aristo Bio-Tech & Lifescience planning?

See what Aristo Bio-Tech & Lifescience Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Aristo Bio-Tech & Lifescience raising money or cutting debt?

"Increase in share capital (IPO)" and "Security Premium (IPO)" rows show nil.

Locked: what Aristo Bio-Tech & Lifescience Ltd said on fundraising

Also locked on this page: margins, capex, order book

Free account, 30 seconds. No card needed.

How big is Aristo Bio-Tech & Lifescience's order book?

See what Aristo Bio-Tech & Lifescience Ltd said on order book & pipeline — free account, 30 seconds.

More Q2 FY27 results in Fertilizers & Agrochemicals

All Q2 FY27 results | Fertilizers & Agrochemicals rankings

Others in Fertilizers & Agrochemicals this season

  • Madhya Bharat Agro Products (Q2 FY27)

    Q2 FY27 Revenue: ₹715 crore, up 59% YoY (Page 12, Chairman’s Quote) . Key investor presentation takeaways from Madhya Bharat Agro Products Ltd's Q2 FY27 investo

  • Dhansa Labs (Q2 FY27)

    1,864 crores during H1 FY27. Key results statement takeaways from Dhansa Labs Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Krishana Phoschem (Q2 FY27)

    Year-on-year revenue growth: Rs 70,254.28 Lakhs vs Rs 60,786.41 Lakhs (~15.6% increase) . Key results statement takeaways from Krishana Phoschem Ltd's Q2 FY27 e

  • Balaji Phosphates (Q2 FY27)

    Year-on-year growth for the half year (Standalone): ~31.4% increase (from Rs. Key results statement takeaways from Balaji Phosphates Ltd's Q2 FY27 results state

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Aristo Bio-Tech & Lifescience Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Aristo Bio-Tech & Lifescience Ltd Q2 FY27 results?

Revenue from operations for the half year ended 30th September 2026 was Rs. 19,824.17 lakh, compared to Rs. 25,645.31 lakh for the half year ended 30th September 2025, indicating a year-on-year decrea. EBITDA for the quarter ended September 30, 2026: Rs. 1,168.88 lakh (calculated as Profit Before Tax + Tax + Finance Cost + Depreciation = 659.84 + 169.65 + 175.57 + 157.33), showing a YoY change com.

What is Aristo Bio-Tech & Lifescience Ltd share price analysis?

Aristo Bio-Tech & Lifescience Ltd currently shows a neutral. The stock trades at a P/E of 11.2 with a market cap of ₹80 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Aristo Bio-Tech & Lifescience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.